Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators -: A practical guide to patient treatment

被引:41
作者
Goldschlager, N
Epstein, A
Friedman, P
Gang, E
Krol, R
Olshansky, B
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA
[4] Mayo Clin & Mayo Grad Sch Med, Dept Med, Rochester, MN 55901 USA
[5] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA
[6] Atlantic Hlth Syst Passaic, Cardiovasc Inst, Arrhythmia & Pacemaker Serv, Passaic, NJ USA
[7] Univ Iowa Hosp & Clin, Dept Med, Div Cardiol, Iowa City, IA 52242 USA
关键词
D O I
10.1001/archinte.161.5.649
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The potential for interaction between pacemakers and implantable cardioverter/ defibrillators (ICDs) and the medical and nonmedical environment, and between these devices and certain cardioactive drugs, has been recognized for years. Whereas a number of experimental and clinical studies have been performed to define some of these interactions, in man): instances data are sparse and anecdotal clinical experiences form the basis for decision making and recommendations. Nevertheless, given the proliferation of rhythm-management devices in use in the population today, practitioners may find a guide to management of these patients helpful. This management guideline is therefore offered not as an extensive, literature-based review, but as a framework on which to understand specific types of problems that may be encountered in the daily lives of patients who have such implanted devices.
引用
收藏
页码:649 / 655
页数:7
相关论文
共 21 条
[1]   Electromagnetic interference of digital and analog cellular telephones with implantable cardioverter defibrillators: In vitro and in vivo studies [J].
Barbaro, V ;
Bartolini, P ;
Bellocci, F ;
Caruso, F ;
Donato, A ;
Gabrielli, D ;
Militello, C ;
Montenero, AS ;
Zecchi, P .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1999, 22 (04) :626-634
[2]   EFFECTS OF ORAL PROPAFENONE THERAPY ON CHRONIC MYOCARDIAL PACING THRESHOLD [J].
BIANCONI, L ;
BOCCADAMO, R ;
TOSCANO, S ;
SERDOZ, R ;
CARPINO, A ;
IESI, AP ;
ALTAMURA, G .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (02) :148-154
[3]   ICD-antiarrhythmic drug and ICD-pacemaker interactions [J].
Brode, SE ;
Schwartzman, D ;
Callans, DJ ;
Gottlieb, CD ;
Marchlinski, FE .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1997, 8 (07) :830-842
[4]  
Carnes CA, 1998, PHARMACOTHERAPY, V18, P516
[5]   THE EFFECT OF METAL DETECTOR GATES ON IMPLANTED PERMANENT PACEMAKERS [J].
COPPERMAN, Y ;
ZARFATI, D ;
LANIADO, S .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1988, 11 (10) :1386-1387
[6]   Digital cellular telephone interaction with implantable cardioverter-defibrillators [J].
Fetter, JG ;
Ivans, V ;
Benditt, DG ;
Collins, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (03) :623-628
[7]   Interactions between electronic article surveillance systems and implantable cardioverter-defibrillators [J].
Groh, WJ ;
Boschee, SA ;
Engelstein, ED ;
Miles, WM ;
Burton, ME ;
Foster, PR ;
Crevey, BJ ;
Zipes, DP .
CIRCULATION, 1999, 100 (04) :387-392
[8]   Interference with cardiac pacemakers by cellular telephones [J].
Hayes, DL ;
Wang, PJ ;
Reynolds, DW ;
Estes, NAM ;
Griffith, JL ;
Steffens, RA ;
Carlo, GL ;
Findlay, GK ;
Johnson, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (21) :1473-1479
[9]   EFFECT OF THE ANTI-ARRHYTHMIC AGENT FLECAINIDE ACETATE ON ACUTE AND CHRONIC PACING THRESHOLDS [J].
HELLESTRAND, KJ ;
BURNETT, PJ ;
MILNE, JR ;
BEXTON, RS ;
NATHAN, AW ;
CAMM, AJ .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1983, 6 (05) :892-899
[10]   ELECTROPHYSIOLOGIC EFFECTS OF FLECAINIDE ACETATE ON SINUS NODE FUNCTION, ANOMALOUS ATRIOVENTRICULAR CONNECTIONS, AND PACEMAKER THRESHOLDS [J].
HELLESTRAND, KJ ;
NATHAN, AW ;
BEXTON, RS ;
CAMM, AJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (05) :B30-B38